Trump's pharmaceutical tariffs could affect some drugmakers more than others

cnbc.com/2025/07/29/trumps-pharmaceutical-tariffs-novartis-roche-could-be-most-at-risk.html

AbbVie, Bristol Myers Squibb and Eli Lilly appear "relatively well-positioned," while Novartis and Roche look more at risk, TD Cowen analyst Steve Scala said.

This story appeared on cnbc.com, 2025-07-29 19:16:47.
The Entire Business World on a Single Page. Free to Use →